THERANEXUS
Theranexus is a clinical-stage pharmaceutical company that aims to develop technology to address severe medical needs in brain disorders. The company is based in France.
THERANEXUS
Industry:
Medical Therapeutics
Founded:
2013-01-01
Address:
Orsay, Ile-de-France, France
Country:
France
Website Url:
http://www.theranexus.com
Total Employee:
1+
Status:
Active
Total Funding:
3.6 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager Google Universal Analytics Font Awesome Apache
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Theolytics
Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.
Vetsource
Vetsource provides comprehensive solutions to those who care for pets - veterinarians and pet owners.
Current Employees Featured
Mathieu Charvériat CSO & Co-founder @ Theranexus
CSO & Co-founder
2013-04-01
Franck Mouthon Co-Founder, Chairman & Chief Executive Officer @ Theranexus
Co-Founder, Chairman & Chief Executive Officer
Thierry Lambert Chief Financial Officer @ Theranexus
Chief Financial Officer
2017-09-01
Julien V. Chief Business Development Officer @ Theranexus
Chief Business Development Officer
2016-01-01
Founder
Stock Details
Investors List
CEA Investissement
CEA Investissement investment in Seed Round - Theranexus
Rhone-Alpes Creation
Rhone-Alpes Creation investment in Seed Round - Theranexus
Sofimac Investment Managers
Sofimac Investment Managers investment in Seed Round - Theranexus
Auriga Partners
Auriga Partners investment in Seed Round - Theranexus
Wilco
Wilco investment in Seed Round - Theranexus
Official Site Inspections
http://www.theranexus.com
- Host name: ds-195-199.dri-services.net
- IP address: 46.18.195.199
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Theranexus"
Theranexus - Crunchbase Company Profile & Funding
Organization. Theranexus . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Theranexus is a clinical-stage pharmaceutical company that aims to develop technology to …See details»
> Mission - Theranexus
Founded in 2013 by two CEA researchers, Franck Mouthon and Mathieu Charveriat, Theranexus is a biopharmaceutical company developing drug candidates for the treatment of rare …See details»
INVESTOR ACCESS PRESENTATION - Theranexus
Theranexus Financing academic studies Discovery of disease mechanisms by Dr Sardiello of Baylor College of medicine (Palmieri et al. Nat Com 2017) Created in 2008 by Craig Benson …See details»
Theranexus - LinkedIn
Theranexus Biotechnology Research Lyon, Auvergne-Rhône-Alpes 4,665 followers Theranexus is a biopharmaceutical company that develops drug candidates to be used in the treatment of central nervous.See details»
Theranexus Company Profile 2024: Stock Performance & Earnings
Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. ... The drug …See details»
Theranexus - Funding, Financials, Valuation & Investors - Crunchbase
Theranexus is a clinical-stage pharmaceutical company that aims to develop technology to address severe medical needs in brain disorders. Search Crunchbase. ... How much funding …See details»
Theranexus announces positive data on efficacy and safety in the …
Beyond Batten Disease Foundation (BBDF) is the world’s largest nonprofit organization dedicated to funding research for a treatment and cure for juvenile (CLN3) Batten disease. Since its …See details»
Theranexus Company Profile - Office Locations, Competitors
Sep 20, 2024 Theranexus, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The Company's lead drug candidate includes …See details»
THERANEXUS, BBDF AND CARDIFF UNIVERSITY PRESENT THEIR …
Feb 22, 2023 Theranexus CEO, Mathieu Charvériat explains: ... Beyond Batten Disease Foundation (BBDF) is the world’s largest nonprofit organization dedicated to funding research …See details»
Theranexus and BBDF win FDA approval on efficacy endpoints for …
May 9, 2023 3 National Organization for Rare Disorders (NORD)/Orphanet. 4 Settembre et al, TFEB links autophagy to lysosomal biogenesis, Science 2011. About Theranexus. Theranexus …See details»
Theranexus, treatment for rare neurological diseases
Theranexus is an innovative biopharmaceutical company born from the CEA. It is developing what is currently the most advanced drug candidate in the world to slow the progression of Juvenile …See details»
Theranexus : Theranexus and BBDF win FDA approval on efficacy …
May 9, 2023 Its valuable guidance allows us to get fully prepared for the trial launch," explained Theranexus' Chief Medical Officer Marie Sebille. ... Beyond Batten Disease Foundation …See details»
Microsoft Word - Theranexus_PR_2022_FYR_VDEF.docx
O Strategic focus on rare neurological diseases and new milestone in company organization In April 2022, Theranexus opted to focus on rare neurological diseases to concentrate R&D on …See details»
Theranexus and BBDF Win FDA Approval on Efficacy Endpoints for …
May 9, 2023 Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases, and the Beyond Batten Disease Foundation (BBDF), have today …See details»
Theranexus : Theranexus publishes its 2021 full-year results And ...
Lyon, France – 25 April 2022 – 7:00 am CEST –Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer in the development of drug …See details»
Update on the Theranexus' Batten-1 project in CLN3 Batten's disease
Nov 19, 2024 A communication by BBDF and Theranexus of the promising results of the Batten-1 Phase I/II trial at the Child Neurology Society Annual Meeting in San Diego (California) ...See details»
THERANEXUS - THERANEXUS PUBLISHES ITS 2022 FULL-YEAR …
Apr 12, 2023 Strategic focus on rare neurological diseases and new milestone in company organization; In April 2022, Theranexus opted to focus on rare neurological diseases to …See details»
Microsoft Word
1 THERANEXUS PUBLISHES ITS 2021 FULL-YEAR RESULTS AND ANNOUNCES A SHIFT OF ITS STRATEGIC FOCUS TO RARE NEUROLOGICAL DISEASES Lyon, France – 25 April …See details»
THERANEXUS : and BBDF start recruitment for phase I/II trial in …
Feb 3, 2022 Lyon, France - Austin, TX, USA - 3 February 2022 - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases and pioneer …See details»